Previous close | 0.0760 |
Open | 0.0740 |
Bid | 0.0730 x 0 |
Ask | 0.0760 x 0 |
Day's range | 0.0730 - 0.0760 |
52-week range | 0.0730 - 0.3758 |
Volume | |
Avg. volume | 179,473 |
Market cap | 22.357M |
Beta (5Y monthly) | 1.53 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ATCOR Medical, subsidiary of CardieX and developer of innovative medical devices and digital solutions to personalize healthcare and improve clinical trial patient outcomes, today announces it has entered into a partnership agreement with Datacubed Health, a leading eClinical technology company, advancing access to healthcare for everyone, everywhere.
Cardiovascular health technology company, CardieX Limited, is pleased to announce it has been selected as part of MedTech Innovator's 2023 Accelerator Cohort.
ATCOR Medical, a subsidiary of CardieX and developer of innovative medical devices and digital health solutions to optimize hypertension management and improve clinical trial patient outcomes, today announced it has launched a single-center retrospective study of 2,000 hypertensive patients to identify associated care outcomes resulting from the routine monitoring of central aortic blood pressure (cBP) and peripheral blood pressure (pBP). With over six years of patient data, this longitudinal st